Management of Interval Enlargement of Aortopulmonary Lymph Node

Initial Assessment and Diagnostic Approach

The American College of Chest Physicians recommends invasive tissue sampling via EBUS-NA, EUS-NA, or combined EBUS/EUS-NA as the first-line diagnostic approach for interval enlargement of aortopulmonary lymph nodes, with surgical staging reserved for cases where needle techniques are negative but clinical suspicion remains high 1
Interval growth of any magnitude in lymph nodes warrants further evaluation, regardless of absolute size, particularly for nodes <10 mm 2

PET imaging is recommended to evaluate for additional sites of disease and guide biopsy planning, particularly to identify the most metabolically active site for sampling and to screen for distant metastases that would alter management 1
The use of thin-section CT (1.5 mm slices) is recommended to accurately document short-axis diameter measurement, loss of fatty hilum, border characteristics, and associated pulmonary findings 3, 4

Patient demographics, such as young males with enlarged mediastinal nodes, require consideration of lymphoma, seminoma, and non-seminomatous germ cell tumors 3, 4, 5
Systemic symptoms like fever, night sweats, and weight loss warrant immediate evaluation regardless of node size 3
Known primary malignancy, particularly lung cancer, where aortopulmonary nodes represent N2 disease, requires careful assessment 1